Skip to main content

Advertisement

Log in

From resveratrol to ISIDE11: how to activate SIRT1 and improve endothelial function? New therapeutic insights for methylenetetrahydrofolate reductase deficiency

  • Commentary
  • Published:
Cellular and Molecular Life Sciences Aims and scope Submit manuscript

The Original Article was published on 11 July 2022

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Data availability

Enquiries about data availability should be directed to the authors.

References

  1. Raghubeer S, Matsha TE (2021) Methylenetetrahydrofolate (MTHFR), the one-carbon cycle, and cardiovascular risks. Nutrients 13:4562

    Article  CAS  Google Scholar 

  2. Lemarie CA et al (2011) Mthfr deficiency induces endothelial progenitor cell senescence via uncoupling of eNOS and downregulation of SIRT1. Am J Physiol Heart Circ Physiol 300:H745-753

    Article  CAS  Google Scholar 

  3. Parmeggiani F et al (2019) Impact of methylenetetrahydrofolate reductase C677T polymorphism on the efficacy of photodynamic therapy in patients with neovascular age-related macular degeneration. Sci Rep 9:2614

    Article  Google Scholar 

  4. Carrizzo A (2022) SIRT1 pharmacological activation rescues vascular dysfunction and prevents thrombosis in MTHFR deficiency. CMLS. https://doi.org/10.1007/s00018-022-04429-5

    Article  PubMed  Google Scholar 

  5. Bonnefont-Rousselot D (2016) Resveratrol and cardiovascular diseases. Nutrients 8:250

    Article  Google Scholar 

  6. Santulli G et al (2014) A selective microRNA-based strategy inhibits restenosis while preserving endothelial function. J Clin Invest 124:4102–4114

    Article  Google Scholar 

  7. Reagan A et al (2020) A common risk variant in the MTHFR gene contributes to age-related cerebrovascular dysfunction in VCID. Alzheimer’s Dementia 16:e038657

    Article  Google Scholar 

  8. Li Y et al (2020) Association between MTHFR C677T/A1298C and susceptibility to autism spectrum disorders: a meta-analysis. BMC Pediatr 20:449

    Article  CAS  Google Scholar 

  9. Carafa V, Nebbioso A, Altucci L (2012) Sirtuins and disease: the road ahead. Front Pharmacol 3:4

    Article  CAS  Google Scholar 

  10. Yang Q et al (2012) Prospective study of methylenetetrahydrofolate reductase (MTHFR) variant C677T and risk of all-cause and cardiovascular disease mortality among 6000 US adults. Am J Clin Nutr 95:1245–1253

    Article  CAS  Google Scholar 

  11. Cappuccio G et al (2014) Pearls & oy-sters: familial epileptic encephalopathy due to methylenetetrahydrofolate reductase deficiency. Neurology 83:e41-44

    Article  Google Scholar 

  12. Wan L et al (2018) Methylenetetrahydrofolate reductase and psychiatric diseases. Transl Psychiatry 8:242

    Article  Google Scholar 

Download references

Funding

The Santulli’s Lab is supported in part by the National Institutes of Health (NIH): National Heart, Lung, and Blood Institute (NHLBI: R01HL164772, R01-HL159062, R01-HL146691, T32-HL144456), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK: R01-DK123259, R01-DK033823) to G.S., by the Diabetes Action Research and Education Foundation (to G.S.), and by the Monique Weill-Caulier and Irma T. Hirschl Trusts (to G.S.). S.S.J. is supported by a postdoctoral fellowship of the American Heart Association (AHA-21POST836407).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Gaetano Santulli.

Ethics declarations

Conflict of interest

None.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Jankauskas, S.S., Mone, P. & Santulli, G. From resveratrol to ISIDE11: how to activate SIRT1 and improve endothelial function? New therapeutic insights for methylenetetrahydrofolate reductase deficiency. Cell. Mol. Life Sci. 79, 451 (2022). https://doi.org/10.1007/s00018-022-04484-y

Download citation

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s00018-022-04484-y

Navigation